• Stable Isotope-Diluted UHPLC–MS/MS for Methylated Purine Nuc

  2026-06-19

  The reference study presents a highly sensitive and precise UHPLC–MS/MS method, leveraging stable isotope dilution to quantify ten methylated purine nucleosides, including 1-methyl Adenosine, in cellular models. This methodological advance enables deeper exploration of RNA modification dynamics, facilitating biomarker discovery and mechanistic insight in disease research.

• Fluconazole: Precision Antifungal Research via 14α-Demethyla

  2026-06-18

  Fluconazole is the gold standard triazole for interrogating fungal cytochrome P450 enzyme 14α-demethylase activity and antifungal resistance in Candida albicans models. This guide delivers actionable, data-driven protocols, advanced troubleshooting, and practical insights to elevate your antifungal susceptibility and pathogenesis workflows.

• Ginsenosides Protect Organs from High-Altitude Hypoxia via P

  2026-06-18

  This study demonstrates that ginsenosides mitigate lung and kidney injuries induced by high-altitude hypoxia by regulating the PHD2/HIF-1α/EPO signaling pathway. The findings provide mechanistic insight into ginsenosides' anti-hypoxic, anti-inflammatory, and antioxidant effects, supporting their potential therapeutic use for altitude-related tissue damage.

• Ethacridine Lactate Monohydrate: Reliable Antiseptic for Cel

  2026-06-17

  This article guides biomedical researchers through real-world laboratory challenges involving cell viability and cytotoxicity assays, highlighting how Ethacridine lactate monohydrate (SKU B1749) addresses microbial inhibition, protocol optimization, and reproducibility. Drawing on quantitative data and validated workflows, it demonstrates why this compound is a trusted choice for sensitive biochemical and cellular research.

• Tomivosertib: Applied Workflows for MNK1 Inhibitor Research

  2026-06-17

  Tomivosertib enables highly selective, reproducible inhibition of MNK1/2, empowering researchers to dissect oncogenic translation and metabolic pathways with precision. This guide translates recent evidence into actionable protocols, troubleshooting insights, and advanced use-cases for glioblastoma and leukemia models.

• Magnetic Stimulation Downregulates GABRE to Reverse SCZ Beha

  2026-06-16

  The referenced study introduces a combined magnetic stimulation system (c-MSST) targeting the left prelimbic cortex to selectively downregulate the GABAA receptor ε subunit (GABRE), resulting in reversal of schizophrenia-like behaviors in mice. This work elucidates a region- and subunit-specific neuromodulatory mechanism, offering new molecular avenues for therapeutic intervention in schizophrenia.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-06-16

  This study uncovers a pyroptosis-independent mechanism by which Gasdermin C (GSDMC) enhances stemness and immune evasion in pancreatic ductal adenocarcinoma (PDAC). The findings identify GSDMC as a key nuclear regulator of cancer progression and immune suppression, suggesting new therapeutic targets for improving immunotherapy responses.

• HotStart 2X Green qPCR Master Mix: Precision in Gene Quantif

  2026-06-15

  The HotStart™ 2X Green qPCR Master Mix redefines SYBR Green qPCR with high specificity, streamlined workflows, and robust reproducibility. Optimal for gene expression analysis and biomarker validation, this APExBIO reagent empowers researchers to decode molecular signatures in challenging samples.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-06-15

  The Hoechst 33342/PI Double Staining Kit provides a standardized approach for rapid, fluorescence-based discrimination of apoptotic, necrotic, and viable cells in cultured cell assays. This kit is intended exclusively for basic research workflows requiring assessment of chromatin condensation and membrane integrity, and should not be used for diagnostic or clinical applications.

• SAR131675: Precision VEGFR-3 Inhibitor for Tumor and Vascula

  2026-06-14

  SAR131675 stands out as a potent, highly selective VEGFR-3 inhibitor for dissecting lymphangiogenesis and angiogenesis in cancer and fibrosis models. This guide distills effective workflow strategies, troubleshooting insights, and protocol parameters to maximize SAR131675's impact in preclinical studies.

• Annexin V-FITC/7-AAD Apoptosis Kit: Practical Use Guide

  2026-06-13

  The Annexin V-FITC/7-AAD Apoptosis Kit offers a rapid, sensitive method for distinguishing apoptotic from necrotic cells in established cell viability and cytotoxicity assays. It is optimized for use with flow cytometry or fluorescence microscopy and is not intended for detailed mechanistic pathway studies. Researchers benefit from clear protocols and defined storage conditions, while avoiding unsupported applications.

• CKI 7 dihydrochloride: Reliable CK1 Inhibition in Cell Assay

  2026-06-12

  This article provides an evidence-based, scenario-driven guide to deploying CKI 7 dihydrochloride (SKU B4936) as a selective Casein kinase 1 inhibitor for cell viability and signaling pathway research. Drawing on current literature and best practices, we address experimental design, optimization, and product reliability—highlighting why CKI 7 dihydrochloride is a trusted solution for reproducible and interpretable data.

• Cabozantinib (XL184): Multiscale Remodeling and RTK Inhibiti

  2026-06-12

  Explore the advanced mechanisms by which Cabozantinib (XL184) disrupts receptor tyrosine kinase signaling and induces phosphoproteomic remodeling in cancer models. This in-depth analysis reveals actionable insights for designing robust antiangiogenic and adaptation studies.

• Calpain Inhibition: Mechanistic Leverage for Translational O

  2026-06-11

  This thought-leadership article explores how Calpain Inhibitor II, ALLM empowers translational oncology by targeting calpain and cathepsin pathways. Drawing from recent findings on lncRNA-mediated FAK regulation in triple negative breast cancer, we bridge mechanistic insight with strategic guidance for apoptosis and protease inhibition assays, especially in leukemia and lymphoma research. Practical protocol recommendations and a critical outlook position APExBIO’s solution as a catalyst for innovative cancer research.

• Translational Protease Inhibition: From Mechanism to High-Im

  2026-06-11

  This thought-leadership article illuminates the strategic, mechanistic, and translational landscape of protease inhibition, offering researchers actionable insights and evidence-based guidance. By synthesizing state-of-the-art findings—including advances in HIV-1 protease autoprocessing assays and cross-domain research in cancer and infectious disease—the article positions the DiscoveryProbe™ Protease Inhibitor Library as a uniquely powerful resource. It distinguishes itself from standard product literature by bridging biological rationale, workflow validation, and the competitive context for next-generation translational research.

16084 records 1/1073 page Next 12345 下5页 Last page